CA
CA · CA · CA-DIN-02541416
OPDUALAG
ATC L01FY02
Last synced from Health Canada Drug Product Database (Canada) on
Identification
ManufacturerBRISTOL-MYERS SQUIBB CANADA
CountryCA (CA)
ATC codeL01FY02
Dispensing—
ReimbursedNo
SourceHealth Canada Drug Product Database (Canada)
Last synced6/11/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"din": "02541416",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "L01FY02",
"schedule": [
"Prescription",
"Schedule D"
],
"drug_code": "103005",
"strengths": [
"240 MG",
"80 MG"
],
"ahfs_class": null,
"substances": [
"NIVOLUMAB",
"RELATLIMAB"
],
"product_categorization": null
}Related drugs
Other records sharing ATC code L01FY02.
- PLOpdualagBristol-Myers Squibb Pharma EEIG
- 🇨🇭OpdualagBristol-Myers Squibb SA
- DKOpdualagBristol-Myers Squibb Pharma EEIG
- ISOpdualagBristol-Myers Squibb Pharma EEIG*
- NOOpdualagBristol-Myers Squibb Pharma EEIG (1)
- FIOpdualagBristol-Myers Squibb Pharma EEIG
- CZOPDUALAGBristol-Myers Squibb Pharma EEIG, Dublin
- BEOpdualag 240 mg - 80 mgBristol-Myers Squibb Pharma
Access this data programmatically
Query OPDUALAG and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.